Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Peritoneal equilibration test].

G Morduchowicz1, T Feldman, D J van Dyk

  • 1Dept. of Nephrology, Beilinson Medical Center, Petah Tikva.

Harefuah
|March 15, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interrogation of Retinal Lipofuscin by Fluorescence Lifetime Imaging Microscopy.

Journal of biophotonics·2025
Same author

Sexual problems in MS: Sex differences and their impact on quality of life.

Multiple sclerosis and related disorders·2023
Same author

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

The evolution of leukaemia from pre-leukaemic and leukaemic stem cells.

Journal of internal medicine·2021
Same author

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

The peritoneal equilibration test helps assess dialysis effectiveness in end-stage renal disease patients. Rapid glucose absorption indicates lower fluid removal, potentially requiring dialysis therapy adjustments.

Area of Science:

  • Nephrology
  • Renal Physiology

Context:

  • End-stage renal disease (ESRD) management.
  • Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment modality for ESRD.
  • Assessing the efficiency of peritoneal dialysis is crucial for patient outcomes.

Purpose:

  • To evaluate the utility of the peritoneal equilibration test (PET) in CAPD patients.
  • To determine the relationship between glucose absorption and creatinine transport during PET.
  • To identify patient profiles that may necessitate adjustments in dialysis therapy.

Summary:

  • A peritoneal equilibration test was performed on 10 ESRD patients on CAPD.
  • The test measures glucose absorption and creatinine transfer across the peritoneal membrane.
  • Patients with high glucose absorption showed reduced ultrafiltration but increased creatinine clearance, suggesting potential need for therapy modification or consideration of hemodialysis.

Related Experiment Videos

Impact:

  • Highlights the importance of individualized dialysis therapy planning.
  • PET results can guide clinical decisions for optimizing CAPD treatment.
  • Identifies a subset of patients who may benefit from alternative dialysis strategies like hemodialysis.